| Literature DB >> 24165581 |
Chi-Ren Liao1, Yu-Ling Ho, Guan-Jhong Huang, Chang Syun Yang, Che-Yi Chao, Yuan-Shiun Chang, Yueh-Hsiung Kuo.
Abstract
One lignanoid compound, isoamericanol B (1), along with four triterpenoid compounds-cis-3-O-p-hydroxycinnamoyloleanolic acid (2), trans-3-O-p-hydroxy cinnamoyloleanolic acid (3), cis-3-O-p-hydroxycinnamoylursolic acid (4), trans-3-O-p-hydroxycinnamoylursolic acid (5) have been isolated for the first time from the leaves of Elaeagnus oldhamii Maxim. Compounds 1-4 significantly inhibited the expression of NO (nitric oxide) produced in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. The IC50 value for inhibition of nitrite production of compound 1 was about 10.3 ± 0.4 μg/mL. In the cell viability test, however, among compounds 1-4 compound 1 did not significantly change cell viability. Therefore, in this study compound 1 possessed anti-inflammatory effects. The result suggests compound 1 as a potential lead compound for the treatment of inflammatory diseases.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24165581 PMCID: PMC6270453 DOI: 10.3390/molecules181113218
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The chemical structures of compounds 1–5.
NMR data (CD3COCD3) of 1. δ in ppm, J in Hz.
| Position | δH | δC |
|---|---|---|
| 1 | - | 129.39 |
| 2 | 7.06 ( | 111.30 |
| 3 | - | 148.50 |
| 4 | - | 147.57 |
| 5 | 6.87 ( | 117.92 |
| 6 | 6.92 ( | 120.30 |
| 7 | 5.18 ( | 78.13 |
| 8 | 4.60 ( | 73.81 |
| 9 | 1.08 ( | 13.71 |
| Phenyl-OMe | 3.83 ( | 56.48 |
| Phenyl-OH | 7.69 ( | - |
| 1′ | - | 132.77 |
| 2′ | 6.87 ( | 118.25 |
| 3′ | - | 143.94 |
| 4′ | - | 142.57 |
| 5′ | 6.86 ( | 115.92 |
| 6′ | 6.79 ( | 123.45 |
| 7′ | 6.38 ( | 129.64 |
| 8′ | 5.76 ( | 131.54 |
| 9′ | 4.38 ( | 59.83 |
| OH | 3.89 (br
| - |
Figure 2Key NOESY (↔) (a) correlations and HMBC connectivities (→) (b) of compound 1.
Cell viability and effect of compounds 1–5 on LPS-induced NO production in macrophages a.
| Compound | Dose (μg/mL) | Cell Viability (% of Control) | No Level | NO Inhibition (% of Control) | IC50 (μg/mL) |
|---|---|---|---|---|---|
| Control | (−) | 98.2 ± 4.4 | −0.1 ± 0.3 | ± | |
| LPS | (+) | 100.5 ± 4.0 | 30.3 ± 2.2 ### | ± | |
| 1 | 2.5 | 100.6 ± 5.9 | 17.6 ± 0.5 *** | 42.0 ± 1.6 | |
| 5 | 97.6 ± 4.3 | 17.5 ± 08 *** | 42.3 ± 2.6 | ||
| 10 | 90.7 ± 3.3 | 15.2 ± 0.4 *** | 49.7 ± 1.4 | 10.3 ± 0.4 | |
| 20 | 88.8 ± 2.6 | 12.0 ± 0.4 *** | 60.4 ± 1.3 | ||
| 2 | 2.5 | 87.2 ± 2.0 | 19.7 ± 1.4 ** | 35.1 ± 4.6 | |
| 5 | 77.9 ± 5.0 | (−) | (−) | ||
| 10 | 43.4 ± 1.6 | (−) | (−) | ||
| 20 | 28.0 ± 2.9 | (−) | (−) | ||
| 3 | 2.5 | 87.6 ± 5.6 | 23.5 ± 1.4 ** | 22.5 ± 4.6 | |
| 5 | 86.6 ± 4.2 | 21.0 ± 0.7 *** | 30.7 ± 2.2 | ||
| 10 | 74.1 ± 3.9 | (−) | (−) | ||
| 20 | 49.7 ± 8.2 | (−) | (−) | ||
| 4 | 2.5 | 90.8 ± 5.4 | 23.0 ± 2.8 *** | 24.2 ± 9.1 | |
| 5 | 87.4 ± 3.1 | 20.8 ± 1.8 *** | 31.3 ± 5.8 | ||
| 10 | 70.3 ± 3.5 | (−) | (−) | ||
| 20 | 47.6 ± 9.7 | (−) | (−) | ||
| 5 | 2.5 | 93.0 ± 8.6 | 20.5 ± 2.6 *** | 32.3 ± 8.6 | |
| 5 | 88.8 ± 5.7 | 19.5 ± 1.8 *** | 35.6 ± 6.1 | ||
| 10 | 88.5 ± 7.4 | 18.4 ± 0.8 *** | 39.3 ± 2.6 | >20 | |
| 20 | 86.5 ± 6.1 | 17.2 ± 0.9 *** | 43.0 ± 3.1 |
a The data were presented as mean ± S.D. for three different experiments performed in triplicate; ### compared with sample of control group; ** p < 0.01, and *** p < 0.001 were compared with LPS-alone group.